Your session is about to expire
← Back to Search
Chemotherapy + Photodynamic Therapy for Cutaneous T-Cell Lymphoma
Study Summary
This trial is studying bexarotene and photodynamic therapy to see how well they work compared with photodynamic therapy alone in treating patients with cutaneous T-cell lymphoma.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Find a Location
Who is running the clinical trial?
Media Library
- I am not currently on any other cancer treatments.It has been over 30 days since I last used cancer treatment creams.I am not currently using any cancer-related steroid treatments.I have never been treated with denileukin diftitox.It has been over 30 days since I last used topical anticancer treatments.I haven't taken high-dose vitamin A or similar drugs in the last 30 days.I am not taking gemfibrozil currently.I am 18 years old or older.I have never had uncontrolled high cholesterol.I have never had pancreatitis or high risk for it.I have not received interferon as a cancer treatment.It has been over 30 days since my last skin cancer treatment with light therapy.I am not receiving radiotherapy to my study lesions, unless my doctor decides it's necessary.I am not using any other cancer treatments.I am not taking any retinoid drugs, high-dose vitamin A, or beta-carotene.My cancer has never been more advanced than stage IIA.I have never had melanoma or invasive squamous cell carcinoma.My skin cancer was confirmed as T-cell lymphoma in the last year.I do not have a history of conditions like lupus, porphyria, albinism, or missing eye lenses.I do not have any gallbladder diseases.I have not had any cancer treatment that affects my whole body.I have not had chemotherapy with drugs made from plants.I don't have any serious illnesses or infections that would stop me from joining the study.My cancer is at an early stage (Stage IB or IIA).My fasting triglycerides are normal, and I may be taking medication for it except gemfibrozil.I am not taking statin and fibrate medications together.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Can individuals participate in this ongoing research?
"Reportedly, clinicaltrials.gov has documented that this experiment is no longer actively looking for participants; its last edit was on December 17th 2013. Despite this study's inactivity, there are still over 1700 other medical trials accepting patients at the present moment."
How many medical facilities are offering this clinical trial to participants?
"This clinical trial is currently enrolling participants from a variety of sites, including H. Lee Moffitt Cancer Center and Research Institute in Tampa, University of Colorado Health Science Center in Aurora, and the University of Alabama at Birmingham Comprehensive Cancer Center in Birmingham. An additional 19 medical centres are also partaking in this research study."
What possible adverse effects can arise from this treatment regimen?
"Due to the Phase 2 trial status of this treatment, our team at Power cautiously assigned it a score of 2 on the safety scale. This is partially based on supporting data for its security but no evidence regarding its efficacy yet."
Share this study with friends
Copy Link
Messenger